Nitric oxide synthesis is increased in cybrid cells with m.3243A>G mutation

International Journal of Molecular Sciences

Volumn 14, Issue 1, 2013, Pages 394-410

  Gamba, Juliana ^a   Gamba, Luana T ^a   Rodrigues, Gabriela S ^a   Kiyomoto, Beatriz H ^a   Moraes, Carlos T ^b   Tengan, Celia H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Arginine; Mitochondria; Mitochondrial disease; Mitochondrial DNA; Nitric oxide

Indexed keywords

ARGININE; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; 4-AMINO-5-METHYLAMINO-2',7'-DIFLUOROFLUORESCEIN DIACETATE; FLUORESCEIN DERIVATIVE; MITOCHONDRIAL DNA;

ADULT; AMINO ACID METABOLISM; ANTIBODY SPECIFICITY; ARTICLE; CHEMICAL REACTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID CELL; INTRACELLULAR SIGNALING; MITOCHONDRIAL RESPIRATION; NITRATION; NITRIC OXIDE SYNTHESIS; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; BIOSYNTHESIS; ELECTRON TRANSPORT; FLUORESCENCE; GENETICS; METABOLISM; MIDDLE AGED; MUSCLE; MUTATION; NITROSATION; PATHOLOGY; SPECTROPHOTOMETRY; TUMOR CELL LINE; VASCULARIZATION; YOUNG ADULT;

ADULT; BLOTTING, WESTERN; CELL LINE, TUMOR; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; FLUORESCEINS; FLUORESCENCE; HUMANS; MIDDLE AGED; MUSCLES; MUTATION; NADPH DEHYDROGENASE; NITRIC OXIDE; NITRITES; NITROSATION; SPECTROPHOTOMETRY; YOUNG ADULT;

EID: 84872195574     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14010394     Document Type: Article

References (42)

1. Ghafourifar, P.; Cadenas, E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 2005, 26, 190-195.
2. Nathan, C.; Xie, Q.W. Nitric oxide synthases: Roles, tolls, and controls. Cell 1994, 78, 915-918.
3. Brown, G.C. Nitric oxide and neuronal death. Nitric Oxide 2010, 23, 153-165.
4. Zeviani, M.; di Donato, S. Mitochondrial disorders. Brain 2004, 127, 2153-2172.
5. Nunnari, J.; Suomalainen, A. Mitochondria: In sickness and in health. Cell 2012, 148, 1145-1159.
6. McFarland, R.; Taylor, R.W.; Turnbull, D.M. A neurological perspective on mitochondrial disease. Lancet Neurol. 2010, 9, 829-840.
7. Goto, Y.; Nonaka, I.; Horai, S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348, 651-653.
8. Sproule, D.M.; Kaufmann, P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: Basic concepts, clinical phenotype, and therapeutic management of melas syndrome. Ann. N. Y. Acad. Sci. 2008, 1142, 133-158.
9. Koga, Y.; Akita, Y.; Junko, N.; Yatsuga, S.; Povalko, N.; Fukiyama, R.; Ishii, M.; Matsuishi, T. Endothelial dysfunction in melas improved by L-arginine supplementation. Neurology 2006, 66, 1766-1769.
10. Koga, Y.; Ishibashi, M.; Ueki, I.; Yatsuga, S.; Fukiyama, R.; Akita, Y.; Matsuishi, T. Effects of L-arginine on the acute phase of strokes in three patients with melas. Neurology 2002, 58, 827-828.
11. Koga, Y.; Akita, Y.; Nishioka, J.; Yatsuga, S.; Povalko, N.; Tanabe, Y.; Fujimoto, S.; Matsuishi, T. L-arginine improves the symptoms of strokelike episodes in melas. Neurology 2005, 64, 710-712.
12. Koga, Y.; Akita, Y.; Nishioka, J.; Yatsuga, S.; Povalko, N.; Katayama, K.; Matsuishi, T. MELAS and L-arginine therapy. Mitochondrion 2007, 7, 133-139.
13. King, M.P.; Koga, Y.; Davidson, M.; Schon, E.A. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol. Cell. Biol. 1992, 12, 480-490.
14. Guevara, I.; Iwanejko, J.; Dembinska-Kiec, A.; Pankiewicz, J.; Wanat, A.; Anna, P.; Golabek, I.; Bartus, S.; Malczewska-Malec, M.; Szczudlik, A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 1998, 274, 177-188.
15. Yoneda, M.; Ikawa, M.; Arakawa, K.; Kudo, T.; Kimura, H.; Fujibayashi, Y.; Okazawa, H. In vivo functional brain imaging and a therapeutic trial of L-arginine in melas patients. Biochim. Biophys. Acta 2012, 1820, 615-618.
16. Kubota, M.; Sakakihara, Y.; Mori, M.; Yamagata, T.; Momoi-Yoshida, M. Beneficial effect of L-arginine for stroke-like episode in MELAS. Brain Dev. 2004, 26, 481-483; Discussion 480.
17. El-Hattab, A.W.; Hsu, J.W.; Emrick, L.T.; Wong, L.J.; Craigen, W.J.; Jahoor, F.; Scaglia, F. Restoration of impaired nitric oxide production in melas syndrome with citrulline and arginine supplementation. Mol. Genet. Metab. 2012, 105, 607-614.
18. Koga, Y.; Povalko, N.; Nishioka, J.; Katayama, K.; Kakimoto, N.; Matsuishi, T. MELAS and L-arginine therapy: Pathophysiology of stroke-like episodes. Ann. N. Y. Acad. Sci. 2010, 1201, 104-110.
19. El-Hattab, A.W.; Emrick, L.T.; Craigen, W.J.; Scaglia, F. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. Mol. Genet. Metab. 2012, 107, 247-252.
20. Naini, A.; Kaufmann, P.; Shanske, S.; Engelstad, K.; de Vivo, D.C.; Schon, E.A. Hypocitrullinemia in patients with melas: An insight into the "melas paradox". J. Neurol. Sci. 2005, 229-230, 187-193.
21. Frandsen, U.; Lopez-Figueroa, M.; Hellsten, Y. Localization of nitric oxide synthase in human skeletal muscle. Biochem. Biophys. Res. Commun. 1996, 227, 88-93.
22. Planitzer, G.; Baum, O.; Gossrau, R. Skeletal muscle fibres show NADPH diaphorase activity associated with mitochondria, the sarcoplasmic reticulum and the NOS-1-containing sarcolemma. Histochem. J. 2000, 32, 303-312.
23. Tengan, C.H.; Kiyomoto, B.H.; Godinho, R.O.; Gamba, J.; Neves, A.C.; Schmidt, B.; Oliveira, A.S.; Gabbai, A.A. The role of nitric oxide in muscle fibers with oxidative phosphorylation defects. Biochem. Biophys. Res. Commun. 2007, 359, 771-777.
24. Vattemi, G.; Mechref, Y.; Marini, M.; Tonin, P.; Minuz, P.; Grigoli, L.; Guglielmi, V.; Klouckova, I.; Chiamulera, C.; Meneguzzi, A.; et al. Increased protein nitration in mitochondrial diseases: Evidence for vessel wall involvement. Mol. Cell. Proteomics 2011, 10, M110.002964.
25. Coman, D.; Yaplito-Lee, J.; Boneh, A. New indications and controversies in arginine therapy. Clin. Nutr. 2008, 27, 489-496.
26. Arakawa, K.; Kudo, T.; Ikawa, M.; Morikawa, N.; Kawai, Y.; Sahashi, K.; Lee, J.D.; Kuriyama, M.; Miyamori, I.; Okazawa, H.; et al. Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. C-11 acetate kinetics revealed by positron emission tomography. Circ. J. 2010, 74, 2702-2711.
27. Desquiret-Dumas, V.; Gueguen, N.; Barth, M.; Chevrollier, A.; Hancock, S.; Wallace, D.C.; Amati-Bonneau, P.; Henrion, D.; Bonneau, D.; Reynier, P.; et al. Metabolically induced heteroplasmy shifting and L-arginine treatment reduce the energetic defect in a neuronal-like model of melas. Biochim. Biophys. Acta 2012, 1822, 1019-1029.
28. Gerard, J.M.; Luisiri, A. A fatal overdose of arginine hydrochloride. J. Toxicol. Clin. Toxicol. 1997, 35, 621-625.
29. Abraham, M.B.; van der Westhuyzen, J.; Khanna, V. Arginine extravasation leading to skin necrosis. J. Paediatr. Child Health 2012, 48, E96-E97.
30. Nisoli, E.; Carruba, M.O. Nitric oxide and mitochondrial biogenesis. J. Cell. Sci. 2006, 119, 2855-2862.
31. Stamler, J.S.; Meissner, G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001, 81, 209-237.
32. Boveris, A.; Costa, L.E.; Poderoso, J.J.; Carreras, M.C.; Cadenas, E. Regulation of mitochondrial respiration by oxygen and nitric oxide. Ann. N. Y. Acad. Sci. 2000, 899, 121-135.
33. Oliveira, K.K.; Kiyomoto, B.H.; Tengan, C.H. Complex I spectrophotometric assay in cultured cells: Detailed analysis of key factors. Anal. Biochem. 2012, doi:10.1016/j.ab.2012.12.002.
34. Medja, F.; Allouche, S.; Frachon, P.; Jardel, C.; Malgat, M.; Mousson de Camaret, B.; Slama, A.; Lunardi, J.; Mazat, J.P.; Lombes, A. Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis. Mitochondrion 2009, 9, 331-339.
35. James, A.M.; Wei, Y.H.; Pang, C.Y.; Murphy, M.P. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem. J. 1996, 318, 401-407.
36. Barrientos, A.; Fontanesi, F.; Diaz, F. Evaluation of the mitochondrial respiratory chain and oxidative phosphorylation system using polarography and spectrophotometric enzyme assays. Curr. Protoc. Hum. Genet. 2009, doi:10.1002/0471142905.hg1903s63.
37. De Wit, L.E.; Sluiter, W. Chapter 9 reliable assay for measuring complex I activity in human blood lymphocytes and skin fibroblasts. Meth. Enzymology 2009, 456, 169-181.
38. Barrientos, A. In vivo and in organello assessment of oxphos activities. Methods 2002, 26, 307-316.
39. Ridnour, L.A.; Sim, J.E.; Hayward, M.A.; Wink, D.A.; Martin, S.M.; Buettner, G.R.; Spitz, D.R. A spectrophotometric method for the direct detection and quantitation of nitric oxide, nitrite, and nitrate in cell culture media. Anal. Biochem. 2000, 281, 223-229.
40. Miranda, K.M.; Espey, M.G.; Wink, D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5, 62-71.
41. Kojima, H.; Nakatsubo, N.; Kikuchi, K.; Kawahara, S.; Kirino, Y.; Nagoshi, H.; Hirata, Y.; Nagano, T. Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Anal. Chem. 1998, 70, 2446-2453.
42. Haqqani, A.S.; Kelly, J.F.; Birnboim, H.C. Selective nitration of histone tyrosine residues in vivo in mutatect tumors. J. Biol. Chem. 2002, 277, 3614-3621.